SPONSOR
Essen Biotech
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2
Conditions studied: CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (Locally Advanced or Metastatic)Prostate Cancer - RecurrentPancreatic Ductal Adenocarcinoma (PDAC)Ovarian CancerGlioblastomaMelanoma (Skin Cancer)Acute Myeloid Leukemia (AML)
Essen Biotech is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Cancer, Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (Locally Advanced or Metastatic).
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Essen Biotech
How many clinical trials has Essen Biotech sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Essen Biotech, of which 3 are actively recruiting participants. These trials cover conditions including Cancer, Breast Cancer, Non-Small Cell Lung Cancer (NSCLC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Essen Biotech research focus on?
Essen Biotech clinical trials span Cancer, Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (Locally Advanced or Metastatic), Prostate Cancer - Recurrent, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Essen Biotech clinical trial?
To participate in a Essen Biotech trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Essen Biotech trials with current recruitment status updated daily.
Clinical Trials by Essen Biotech
NCT07410494 Phase 1, Phase 2
Recruiting
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Cancer
NCT06532799 Phase 1, Phase 2
Recruiting
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
Stomach Cancer
NCT07067255 Phase 1, Phase 2
Recruiting
Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer
Ovarian Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology